With an in-depth look at the proto-oncogenes in our results, we find that the epidermal growth factor receptor (EGFR) is a molecular target, which is a transmembrane protein involved in the autocrine growth of melanoma cells, and the overexpression of EGFR has been reported to result in BRAFi/MEKi resistance [40]. This evidence concerns the gene EGFR and melanoma.